![](/documents/10803/74541/NewsroomBanner.png/244aa03d-f521-4d0c-8ae3-8eb9ee11be0a?t=1394637349294)
Breadcrumb
- News and Events
- News
- Content
- Interdisciplinary Consortium Receives Grant to Develop Next-Generation Cell-Based Cancer Vaccines
null Interdisciplinary Consortium Receives Grant to Develop Next-Generation Cell-Based Cancer Vaccines
June 17, 2020
Source: Saint-Gobain Life Sciences. Cell-based cancer vaccines are revolutionizing the treatment of previously incurable cancers. Access to these promising therapies is limited by the high costs of manufacturing at centralized locations. Saint-Gobain Life Sciences, Kanyr Pharma Inc., the Research Institute of the McGill University Health Centre and McGill University have formed a new interdisciplinary consortium to make this technology more accessible. Read more.
![Development of Optimized Culture Environments for Dendritic Cell Cancer Vaccines Development of Optimized Culture Environments for Dendritic Cell Cancer Vaccines](/documents/10803/946541/Interdisciplinary+Consortium+Receives+Grant+to+Develop+Next-Generation+Cell-Based+Cancer+Vaccines+EN.png/df0b6b92-0dc6-49d0-e86a-c8cd9da008aa?t=1593198386453)